Bengaluru, May 26 -- The shares of the Pharma company, specializing in developing and distributing pharmaceuticals for respiratory, dermatology, and oncology conditions, jumped upto 4 percent upon declaring Q4 results and announcing a 250 percent Dividend.

With a market capitalization of Rs. 39,554.68 crores on Monday, the shares of Glenmark Pharmaceuticals Ltd jumped upto 4.02 percent in Intraday trade, making a high of Rs. 1430.50 per share compared to its open price of Rs. 1375.15 per share.

Glenmark Pharmaceuticals Ltd, engaged in the research, development, manufacturing, and marketing of pharmaceutical products, including both generic and branded formulations, as well as Active Pharmaceutical Ingredients (APIs), has announced its Q...